NASDAQ: SBFM
Sunshine Biopharma Inc Stock Ownership - Who owns Sunshine Biopharma?

Insider buying vs selling

Have Sunshine Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SBFM insiders and whales buy or sell their stock.

SBFM Shareholders

What type of owners hold Sunshine Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Malek Chamoun81.21%3,700,000$5.77MInsider
Camille Sebaaly3.83%174,465$272.17kInsider
Steve N. Slilaty2.85%130,000$202.80kInsider
Altium Capital Management LLC1.11%50,466$78.73kInstitution
Ubs Group Ag0.44%19,885$31.02kInstitution
Sbi Securities Co Ltd0.11%5,223$8.15kInstitution
Morgan Stanley0.08%3,834$5.98kInstitution
National Bank Of Canada0.00%10$15.60Institution
Bank Of America Corp0.00%5$7.80Institution
Osaic Holdings Inc0.00%2$3.12Institution

1 of 2

SBFM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SBFM1.74%87.90%
SXTC0.14%0.00%
IXHL1.71%15.45%
BFRI15.67%5.80%
SNOA0.86%99.14%

Sunshine Biopharma Stock Ownership FAQ

Who owns Sunshine Biopharma?

Sunshine Biopharma (NASDAQ: SBFM) is owned by 1.74% institutional shareholders, 87.90% Sunshine Biopharma insiders, and 10.36% retail investors. Malek Chamoun is the largest individual Sunshine Biopharma shareholder, owning 3.70M shares representing 81.21% of the company. Malek Chamoun's Sunshine Biopharma shares are currently valued at $5.90M.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.